|
JAZZ | Jazz Pharmaceuticals Plc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.31 |
| Leverage | 56.67% |
| Market Cap | $ 15.5B |
| PE | 16.52 |
| Dividend Yield | 0.00% |
| Profit | $ 938.5m |
| Margin | 20.46% |
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and markets pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Dublin, Ireland.